The RENEW Trial: A National, Multicenter Study of High-Dose Peginterferon Alfa-2B + Ribavirin for Non-Responders with Hepatitis C
The RENEW Trial: A National, Multicenter Study of High-Dose Peginterferon Alfa-2B + Ribavirin for Non-Responders with Hepatitis C. Hepatology. 2003; 38(4):312-13A.